Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study.
Centre Pluridisciplinaire d'Oncologie, Lausanne, Suisse.
L
L
Perey
G
G
Rosti
A
A
Lange
S
S
Pampallona
L
L
Bosquée
F
F
Pasini
Y
Y
Humblet
O
O
Hamdan
G L
GL
Cetto
M
M
Marangolo
S
S
Leyvraz
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects; D018288:Carcinoma, Small Cell / Q000188:drug therapy* / Q000628:therapy*; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects; D005060:Europe; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000009:adverse effects; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000628:therapy*; D008297:Male; D008875:Middle Aged
D005047:Etoposide; D016190:Carboplatin; D007069:Ifosfamide